Reviewing Micron Solutions (OTCMKTS:MICR) & NeurAxis (NASDAQ:NRXS)

Volatility & Risk

Micron Solutions has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.22, indicating that its share price is 322% more volatile than the S&P 500.

Valuation & Earnings

This table compares Micron Solutions and NeurAxis”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Micron Solutions	$22.57 million	0.00	-$1.29 million	($0.43)	0.00
NeurAxis	$2.46 million	7.47	-$14.63 million	($1.84)	-1.39

Micron Solutions has higher revenue and earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Micron Solutions, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Micron Solutions and NeurAxis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Micron Solutions	N/A	N/A	N/A
NeurAxis	-492.76%	N/A	-641.25%

Insider and Institutional Ownership

11.8% of NeurAxis shares are held by institutional investors. 26.1% of Micron Solutions shares are held by company insiders. Comparatively, 15.2% of NeurAxis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Micron Solutions beats NeurAxis on 7 of the 10 factors compared between the two stocks.

About Micron Solutions

Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.